Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia.

The article discusses the impact of treatment on children with down syndrome associated acute lymphoblastic leukaemia and reduction drug doses. Topics discussed include toxicity caused corticosteroid therapy, especially dexamethasone to regulate immune suppression, white blood cell count or immunophenotype.